Aclaris Therapeutics
ACRS
ACRS
71 hedge funds and large institutions have $33.4M invested in Aclaris Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
43% less capital invested
Capital invested by funds: $58.2M → $33.4M (-$24.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
71
Holding in Top 10
–
Calls
$7K
Puts
$1K
Top Buyers
| 1 | +$2.71M | |
| 2 | +$1.71M | |
| 3 | +$1.36M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.35M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$587K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.25M | |
| 3 | -$533K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$210K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$165K |